Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

In the subsection “Factors associated with response”, the following incorrect statement was made: “In this group, it was observed that four maintained CR (3 patients that had received three doses and 1 patient that have received one dose).”

This sentence should have read: “In this group, it was observed that four maintained CR (three patients that had received three doses and one patient that had received five doses).”